Sklyanik, I. A., & Shestakova, M. V. (2021). Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day. "Consilium Medicum" Publishing house.
Cita Chicago Style (17a ed.)Sklyanik, Igor A., y Marina V. Shestakova. Prognostic Factors for the Carbohydrate Metabolism Normalization in Patients with Type 2 Diabetes Mellitus and Obesity Using Liraglutide 3.0 Mg Per Day. "Consilium Medicum" Publishing house, 2021.
Cita MLA (8a ed.)Sklyanik, Igor A., y Marina V. Shestakova. Prognostic Factors for the Carbohydrate Metabolism Normalization in Patients with Type 2 Diabetes Mellitus and Obesity Using Liraglutide 3.0 Mg Per Day. "Consilium Medicum" Publishing house, 2021.
Precaución: Estas citas no son 100% exactas.